by tmourit | Sep 11, 2026 | Audits, Quality
Many organizations treat vendor qualification as an onboarding task. The supplier completes a questionnaire, provides a certification, and is added to the approved supplier list. Unless a significant problem occurs, the qualification file may not be reviewed again for... by tmourit | Sep 6, 2026 | Audits, Quality
Receiving an FDA Form 483 does not automatically mean that FDA has made a final determination that the company violated the law. It does mean that FDA investigators observed conditions they considered objectionable and significant enough to formally document. A... by tmourit | Aug 6, 2026 | Audits, Quality
A quality system can appear complete on paper and still fail during an audit or regulatory inspection. The problem is often not that a company lacks procedures. The problem is that its procedures, records, training documentation, and actual practices do not... by tmourit | Jun 12, 2026 | Audits, Quality
Corrective and Preventive Action (CAPA) is one of the most important elements of a quality management system. Regulators and auditors view CAPA as evidence of an organization’s ability to identify issues, investigate root causes, implement corrective actions,... by tmourit | Jun 5, 2026 | Audits, Quality
FDA inspections are a critical part of ensuring life science companies maintain compliance with applicable regulations and quality system requirements. Whether your organization operates in the medical device, pharmaceutical, biotechnology, diagnostic, or clinical... by tmourit | May 29, 2026 | Audits, Quality
Understanding FDA 483 Observations An FDA Form 483 is issued when an FDA investigator identifies conditions that may violate the Food Drug and Cosmetic Act or related regulations during an inspection. Receiving a 483 does not automatically mean a company will receive...